Amniocentesis is the most commonly prescribed invasive test performed during pregnancies in the United States. Researchers at Mount School of Medicine in conjunction with other institutions in the FASTER trial report that pregnancy miscarriage rates after routine midtrimester amniocentesis are significantly lower than rates previously published years ago in the 1970s and 1980s- 0.5% or 1 in 200 pregnancies.
The Office of the US Attorney General announced today The Mount Sinai Medical Center will be one of five recipients of a prescription drug education grant for health care professionals. The $400,000 grant is funded by the Attorney General Consumer and Prescriber Education Grant Program and will be used to educate physicians and medical students about pharmaceutical company marketing practices and promote evidence-based prescribing practices.
The National Palliative Care Research Center, Mount Sinai School of Medicine, has been awarded a $5 million grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH).
The Mount Sinai Medical Center and The Samuel Waxman Cancer Research Foundation honor the NIH scientists who helped develop FDA-approved cervical cancer vaccine. More than 150 distinguished guests and eminent physicians will host an award lecture recognizing the two NIH scientists whose research resulted in the clinical development of the Human Papillomavirus (HPV) vaccine against cervical cancer.
A recent study directed by Mount Sinai School of Medicine (MSSM) suggests that seniors with low incomes or no prescription coverage were less likely to use generic cardiovascular drugs than more affluent seniors and those with prescription drug coverage.
After Hurricane Katrina, there has been a nationwide emphasis on getting emergency preparedness information to residents in coastal areas. New York City is no exception. Researchers have just reported that the Costal Storm Plan (CSP) and Geographic Information System (GIS) Map are unclear to certain target populations.
An analysis of mice infected with the reconstructed 1918 influenza virus has revealed that although the infection triggered a very strong immune system response, the response failed to protect the animals from severe lung disease and death.
A new study directed by Mount Sinai School of Medicine has found that moderate red wine consumption in a form of Cabernet Sauvignon may help reduce the incidence of Alzheimer's Disease (AD).
A new study directed by Mount Sinai School of Medicine extends and strengthens the research that experimental dietary regimens might halt or even reverse symptoms of Alzheimer's Disease (AD). Restricting caloric intake may prevent AD by triggering activity in the brain associated with longevity.
The National Education Alliance for Borderline Personality Disorder (NEA-BPD), the Department of Psychiatry, Mount Sinai School of Medicine, and the National Alliance on Mental Illness New York City Metro are co-sponsoring a one-day conference on Friday, September 29 that The Mount Sinai Medical Center, Hatch Auditorium, Madison Avenue at East 100th Street, from 8 am to 5:00 pm.
A study led by researchers at Mount Sinai School of Medicine has shown that a cell-regulating gene overexpressed in about 30 to 50 percent of all breast cancers is associated with a better chance of survival and increased sensitivity to a cancer-fighting drug. The study appears in the September 6 issue of Journal of the National Cancer Institute.
According to a new study conducted by researchers at Mount Sinai School of Medicine, variations of a gene related to brain development and function"”OLIG2"”may play a causal role in the development of schizophrenia, a hereditary psychiatric disorder with no known biological cause.
According to a landmark study by researchers at Mount Sinai School of Medicine, heart failure (HF) patients who received routine follow-up by a nurse in addition to visits to a physician had fewer hospitalizations and functioned better than patients who received only usual care. The study appears in the August 15, 2006 issue of the Annals of Internal Medicine.
The Mount Sinai Medical Center has been named a Bariatric Surgery Center of Excellence by the American Society for Bariatric Surgery (ASBS). This new designation recognizes the safety, efficiency and overall positive surgical results of the bariatric surgical team at Mount Sinai. The hospital has satisfactorily met the high standards set forth by the ASBS to be acknowledged for its excellence in bariatric surgery.
The Global Health Center (GHC) at Mount Sinai has received a $1 million dollar grant from the Mulago Foundation, a nonprofit organization dedicated to humanitarian aid. Distributed over a three-year period, the grant will support faculty and finance curriculum development, international research and trips to developing countries.
Mount Sinai School of Medicine today announced that it has entered into a territory limited license agreement with Avimex* Animal Health. The privately owned world-leader in the avian influenza H5 emulsified vaccine market will use Mount Sinai's patented live recombinant Newcastle disease technology that contains an insertion of the H5 gene, for use in Brazil, India, Japan, Mexico, and Taiwan.
Over one hundred students from several NYC public high schools will be recognized and given academic awards for completing rigorous pre-med coursework at Mount Sinai School of Medicine.
Researchers at Mount Sinai School of Medicine have found that an improved version of the non-invasive fecal DNA (fDNA) test to screen for colon cancer (CRC) demonstrates a higher sensitivity for detecting cancers of the colon. This data will be presented at the Digestive Disease Week (DDW) conference on May 21, 2006 in Los Angeles.
The Seaver and New York Autism Center for Excellence at Mount Sinai School of Medicine announced today that it is entering into an affiliation with the YAI/National Institute for People with Disabilities (YAI/NIPD) Network to offer enhanced programs and greater access to diagnostic services for children and adults with Autism Spectrum Disorders (ASD).
The Mount Sinai Medical Center announced today the creation of Mount Sinai Heart, a new approach to cardiac care that combines all of Mount Sinai's world-class resources"”internationally renowned physicians, scientists and educators, incomparable clinical services, leading-edge research, a first-rate cardiology training program"”under one entity.
A recent study directed by the Mount Sinai School of Medicine suggests a ketogenic-high caloric diet may prevent the progression of Amyotrophic Lateral Sclerosis (ALS). This study, which appears in the April 3, 2006 issue of BMC Neuroscience, is the first to draw a correlation between diet and neuronal cell death, the cause of ALS.
Mount Sinai School of Medicine is the Clinical Coordinating Center for the first study to assess the effectiveness of combining two FDA approved medications as initial treatment for people with Relapsing Remitting Multiple Sclerosis. Sponsored by the National Institutes of Health "“ National Institute of Neurological Disorders and Stroke (NIH-NINDS).
Key Groups to Build on Momentum of National Asbestos Awareness Day During Month of April, Laying Groundwork for Such Events as 17th Annual Workers Memorial Day on April 28th.
The U.S. Department of Energy's Brookhaven National Laboratory and the Mount Sinai School of Medicine (MSSM) have signed an agreement to establish a "Joint Center for Translational Biomedical Imaging."
According to the April issue of Town and Country magazine special section on eating disorders, Mount Sinai Eating and Weight Disorder Program (EWDP) was given the distinction as being the best eating disorders program in New York.
The Mount Sinai School of Medicine announced today it will collaborate with the prestigious Bionostra Group of Spain to develop an avian flu vaccine. The vaccine will protect against the lethal infection of the H5N1 virus.
New implantable sensor helping surgeons monitor post-operative pressure following Endovascular Abdominal Aortic Aneurysm Repair.
Mini-Med School is a free public science education program designed for anyone ever wished that they had a deeper understanding of science. No prior science or medical background is required. All classes run from 6:00 PM "“ 8:00 PM.
Researchers from Mount Sinai School of Medicine identified three proteins that are found in significantly lower concentration in the cerebral spinal fluid of patients with ALS than in healthy individuals. These are the first biomarkers for this disease.
The Interamerican Society of Cardiology honored Dr. Valentin Fuster of Mount Sinai Medical Center, President of the World Heart Federation with The Distinguished Researcher Award in recognition of his contribution to the field of Cardiology.
Presidents and chancellors representing 17 New York universities and institutions with substantial biomedical and life sciences research programs today released a comprehensive analysis of the scientific, therapeutic, and economic issues related to stem cell research.
The WALK study, led by the Mount Sinai School of Medicine and sponsored by Genzyme Corporation, will determine if a new gene transfer treatment, Ad2/HIF-1a/VP16, helps ease the pain caused by intermittent claudication.
New study may lead to improved stem cell therapies for patients with compromised immune systems due to intensive cancer therapy or autoimmune disease. Researchers found that the sympathetic nervous system plays a critical role in coaxing bone marrow stem cells into the bloodstream.
The Spanish Cardiovascular Research Center (CNIC) made a commitment in the amount of 5 million euros, which is nearly $6 million USD, to the Mount Sinai School of Medicine. The contribution will be used to fund the Valentin Fuster Laboratories, new research facilities at the Mount Sinai School of Medicine.
Today, Mount Sinai Hospital, announced that it has signed a three-year strategic alliance agreement with world-renowned diagnostic company Roche Diagnostics, to establish a Molecular Center of Excellence.
Mount Sinai School of Medicine is running several clinical trials to test counseling strategies to help women with a family or personal history of breast and/or ovarian cancer make decisions that are right for them and their family.
The findings of a study indicate a significant independent association between exposure to long term air pollution and the acceleration of atherosclerosis and vascular inflammation in an animal model.
A study confirmed that palliative care programs continue to be a rapidly growing trend in U.S. hospitals "“ a trend widely regarded to be an improvement in the quality of care of advanced, chronic illness.
A huge segment of the population in the New York City metropolitan area could soon benefit from a patient smart card technology program that will help make important health care information more accurate, more secure and more readily available.
Hurricanes this season have left more than physical damage. Mother Nature has also given rise to mental health concerns. Experts in this field at Mount Sinai Medical Center in New York are available for interviews.
How many lives could be saved if we could peer into a "crystal ball" and see what medical threats loom in the future? Researchers may have achieved the medical equivalent when they developed and patented a technique to reconstruct and characterize the Spanish flu of 1918.
Financier Leon D. Black has committed $10 million to Mount Sinai School of Medicine to establish the Black Family Stem Cell Institute. The Institute, which will be directed by Gordon Keller, Ph.D., Professor of Gene and Cell Medicine, will integrate research in embryonic stem cells, developmental biology, and adult stem cell biology.
Mount Sinai Studies Detailed at Annual Scientific Sessions of the American Society for Therapeutic Radiology and Oncology (ASTRO).
At its 2005 Convocation ceremony Mount Sinai School of Medicine honored some of the nation's foremost physicians and scientists.
In order to better predict how targets of drugs can be discovered and better predict side effects of drugs, researchers have developed a computer network model of a molecular community in brain cells of animals that is capable of processing information.
The National Institute of General Medicine Sciences announced today that Mount Sinai School of Medicine and two other centers will receive an estimated $9 million dollar grant over the next three years to further stem cell research.
The Morchand Center for Clinical Competence has launched a new program for dealing with the issue of medical errors. The Program will train medical students, clinicians and other hospital personnel to effectively communicate with patients and family members when a medical error is made.
Three levels of suboptimal asthma and allergy quality of care have been identified among an inner city cohort of high risk asthmatics.
Mount Sinai has a new masters degree program with 3 area of specialty: clinical effectiveness, global public health, environmental health.
The Foxp2 gene plays an essential role in the development of social communication, according to a study. In the study, the team engineered mice with either one or both disrupted copies of Foxp2 in order to examine the role of this gene in social communication.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right